You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rifamycin

Showing 1 - 25 of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Traveler's Diarrhea Trial (Rifamycin SV MMX, Placebo to Rifamycin SV-MMX)

Not yet recruiting
  • Traveler's Diarrhea
  • Rifamycin SV MMX
  • Placebo to Rifamycin SV-MMX
  • (no location specified)
Jan 26, 2023

Traveler's Diarrhea Trial (Rifamycin SV-MMX, Placebo)

Not yet recruiting
  • Traveler's Diarrhea
  • Rifamycin SV-MMX
  • Placebo
  • (no location specified)
Jan 26, 2023

Pulmonology Trial in Taipei (Rifamycin-containing regimen, Rifamycin-free regimen)

Recruiting
  • Pulmonology
  • Rifamycin-containing regimen
  • Rifamycin-free regimen
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 18, 2022

Hepatic Encephalopathy, Cirrhosis, Liver Trial in Richmond (Rifamycin SV MMX, Placebo)

Recruiting
  • Hepatic Encephalopathy
  • Cirrhosis, Liver
  • Rifamycin SV MMX
  • Placebo
  • Richmond, Virginia
    Hunter Holmes McGuire VA Medical Center
Feb 16, 2022

Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

Not yet recruiting
  • Tuberculosis
  • Human Immunodeficiency Virus
  • Optimised rifamycin
  • (no location specified)
Oct 8, 2022

Latent Tuberculosis, Kidney Failure Trial (Rifampicin plus Isoniazid, Rifapentine plus Isoniazid, Rifampicin alone)

Not yet recruiting
  • Latent Tuberculosis
  • Kidney Failure
  • Rifampicin plus Isoniazid
  • +2 more
  • (no location specified)
Aug 24, 2021

Tuberculosis Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (vitamin B6))

Completed
Has Results
  • Tuberculosis
  • Rifapentine (RPT)
  • +2 more
  • Port-au-Prince, Haiti
  • +4 more
Nov 2, 2021

Diarrhea-predominant Irritable Bowel Syndrome Trial in Worldwide (Rifamycin SV 600mg t.i.d., Rifamycin SV b.i.d. + Placebo,

Completed
  • Diarrhea-predominant Irritable Bowel Syndrome
  • Rifamycin SV 600mg t.i.d.
  • +2 more
  • Leuven, Herestraat 49, Belgium
  • +28 more
Jan 7, 2021

Infectious Diarrhoea Trial (400 mg Rifamycin SV dosage, 800 mg Rifamycin SV dosage, 1200 mg Rifamycin SV dosage)

Completed
Has Results
  • Infectious Diarrhoea
  • 400 mg Rifamycin SV dosage
  • +2 more
  • (no location specified)
Feb 5, 2020

Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)

Completed
  • Pulmonary Tuberculosis
  • Cape Town, South Africa
    University of Cape Town Lung Institute
May 18, 2022

Diverticulitis Trial in Seattle (Partial Colectomy, Medical Management)

Recruiting
  • Diverticulitis
  • Partial Colectomy
  • Medical Management
  • Seattle, Washington
    University of Washington
Jan 28, 2022

Pulp Disorder Trial in Sao Paulo (Endodontic treatment using Guedes-Pinto Paste, Endodontic using Guedes-Pinto Paste without

Completed
  • Pulp Disorder
  • Endodontic treatment using Guedes-Pinto Paste
  • Endodontic using Guedes-Pinto Paste without antibiotic
  • Sao Paulo, Brazil
    School of Dentistry, University of Sao Paulo
Apr 17, 2021

Healthy Volunteers Trial run by the CC (Vemlidy (tenofivir alafenamide), Priftin (rifapentine), Isoniazid)

Recruiting
  • Healthy Volunteers
  • Vemlidy (tenofivir alafenamide)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 27, 2022

Traveler's Diarrhea Trial in Ecuador, Guatemala, India (Rifamycin SV-MMX®, Ciprofloxacin)

Completed
Has Results
  • Traveler's Diarrhea
  • Quito, Ecuador
  • +18 more
Oct 16, 2018

Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Indinavir sulfate, Ritonavir, Ethambutol

Completed
  • Mycobacterium Avium-intracellulare Infection
  • HIV Infections
  • Indinavir sulfate
  • +4 more
  • Birmingham, Alabama
  • +33 more
Oct 28, 2021

Adverse Drug Interactions Trial in Seattle (Rifampicin, sulforaphane plus rifampicin, sulforaphane alone)

Completed
Has Results
  • Adverse Drug Interactions
  • Seattle, Washington
  • +1 more
Aug 15, 2019

HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid

Completed
  • HIV Infected Population With Latent Tuberculosis
  • rifapentene (RPT)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 15, 2022

Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ciprofloxacin HCl, Ethambutol HCl, Amikacin sulfate)

Completed
  • Mycobacterium Avium-intracellulare Infection
  • HIV Infections
  • Ciprofloxacin hydrochloride
  • +5 more
  • Torrance, California
  • +15 more
Oct 26, 2021

Drug Exposure and Minimum Inhibitory Concentration in Treatment

Not yet recruiting
  • Mycobacterium Avium Complex
  • +3 more
  • Drug exposure
  • Shanghai, China
    Shanghai Pulmonary Hospital
Apr 10, 2023

HIV-associated Tuberculosis Trial in South Africa, Thailand (Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC,

Not yet recruiting
  • HIV-associated Tuberculosis
  • Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC
  • +3 more
  • Mowbray, Cape Town, Western Cape, South Africa
  • +3 more
Nov 18, 2022

Pharmacokinetics of Atazanavir in Special Populations

Active, not recruiting
  • HIV/AIDS
  • Tuberculosis
  • Atazanavir 300mg/ Ritonavir 100 mg once daily
  • Atazanavir 250 mg / ritonavir 80 mg
  • Cape Town, Western Cape, South Africa
  • +3 more
Sep 22, 2021

Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)

Recruiting
  • Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
  • Aichi, Japan
  • +42 more
Jan 17, 2023

HIV Trial in United States (Indinavir sulfate, Rifabutin)

Completed
  • HIV Infections
  • Los Angeles, California
  • +7 more
Oct 27, 2021

Drug Drug Interaction Trial in Cypress (Fruquintinib, Itraconazole, Rifampin)

Completed
  • Drug Drug Interaction
  • Cypress, California
    WCCT
Jun 16, 2021

Impacted Third Molar Tooth Trial in Van (Rifamycine, Saline Solution)

Active, not recruiting
  • Impacted Third Molar Tooth
  • Van, Tuşba, Turkey
    Van Yuzuncu Yil University, Faculty of Dentistry
Dec 7, 2021